packageFaricimab

faricimab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Faricimab is a monoclonal antibody used to treat eye conditions involving abnormal blood vessel growth, such as wet macular degeneration, macular edema, and complications of diabetes. It is authorised in the European Union and is also under investigation for further uses.

Summary written by glm-5.3-flash from Wikidata Q60785557 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:faricimab
ATC codes:S01LA09
DrugBank:DB15303
Wikidata:Q60785557
molar mass:440 g/mol (Drugs.Common 25.09, not verified)
logP:3.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown